Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 3 |
2019 | 1 |
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13.
N Engl J Med. 2021.
PMID: 33185990
Clinical Trial.
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.
Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bøhmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, A L Buraiki J, Gniot J, Mozheiko M, Lelonek M, Noè A, Schwende H, Bao W, Butylin D, Pascual-Figal D; TRANSITION Investigators.
Wachter R, et al.
Eur J Heart Fail. 2019 Aug;21(8):998-1007. doi: 10.1002/ejhf.1498. Epub 2019 May 27.
Eur J Heart Fail. 2019.
PMID: 31134724
Free article.
Clinical Trial.
Item in Clipboard
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
Pascual-Figal D, Wachter R, Senni M, Bao W, Noè A, Schwende H, Butylin D, Prescott MF; TRANSITION Investigators.
Pascual-Figal D, et al.
JACC Heart Fail. 2020 Oct;8(10):822-833. doi: 10.1016/j.jchf.2020.05.012. Epub 2020 Aug 12.
JACC Heart Fail. 2020.
PMID: 32800508
Free article.
Item in Clipboard
[Heart rate variability in chronic heart failure and its role in prognosis of the disease.].
Arbolishvili GN, Mareev VIu, Orlova IaA, Belenkov IuN.
Arbolishvili GN, et al.
Kardiologiia. 2006;46(12):4-11.
Kardiologiia. 2006.
PMID: 17310956
Russian.
Item in Clipboard
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
Skvortsov AA, Mareev VIu, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Masenko VP, Belenkov IuN.
Skvortsov AA, et al. Among authors: arbolishvili gn.
Ter Arkh. 2006;78(9):61-71.
Ter Arkh. 2006.
PMID: 17076227
Clinical Trial.
Russian.
Item in Clipboard
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
Skvortsov AA, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Mareev VIu, Belenkov IuN.
Skvortsov AA, et al. Among authors: arbolishvili gn.
Ter Arkh. 2005;77(8):34-43.
Ter Arkh. 2005.
PMID: 16206603
Clinical Trial.
Russian.
Item in Clipboard
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
Skvortsov AA, Mareev VIu, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Masenko VP, Belenkov IuN.
Skvortsov AA, et al. Among authors: arbolishvili gn.
Ter Arkh. 2006;78(8):14-20.
Ter Arkh. 2006.
PMID: 17078211
Clinical Trial.
Russian.
Item in Clipboard
Cite
Cite